Finanzwire Finanzwire
Basculer en Français
10184 Companies
209529 Keywords
139629 Articles
111067 Press releases
Headlines Articles Press releases Morphogenesis Inc. Remove
  1. Home
  2. Companies
  3. Morphogenesis Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/25/2024 at 15:05, 1 year 11 months ago

    TuHURA Biosciences to Showcase Clinical Trial Results at ASCO 2024

    Clinical Trials Mergers And Acquisitions TuHURA Biosciences Cancer Immunotherapy ASCO 2024
  • PRESS RELEASE

    published on 04/25/2024 at 15:00, 1 year 11 months ago

    TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

    TuHURA Biosciences, Inc. announces IFx-2.0 Phase 1b trial results accepted for poster presentation at 2024 ASCO Annual Meeting. Company to form new entity with Kintara Therapeutics, Inc. and focus on cancer vaccines and bi-functional ADCs
    Phase 1b Trial TuHURA Biosciences Inc. IFx-2.0 Poster Presentation Kintara Therapeutics Inc.
    Logo of Morphogenesis Inc.
  • PRESS RELEASE

    published on 12/14/2023 at 16:00, 2 years 3 months ago

    Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. and Provides a Business Overview

    Logo of Morphogenesis Inc.
  • PRESS RELEASE

    published on 11/08/2023 at 15:00, 2 years 5 months ago

    Morphogenesis, Inc. Biomarker Analysis Data from IFx-Hu2.0 in Melanoma Refractory to Anti-PD1-Based Therapies Demonstrates Ability to Overcome Primary Resistance to Checkpoint Inhibitors and Trigger an Innate Immune Response

    Logo of Morphogenesis Inc.
Accesswire
  • Published on 04/09/2026 at 16:00, 53 minutes ago

    Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X

  • Published on 04/09/2026 at 14:40, 2 hours 13 minutes ago

    Silver X Delivers Production Growth During the First Quarter of 2026

  • Published on 04/09/2026 at 14:00, 2 hours 53 minutes ago

    Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty

  • Published on 04/09/2026 at 13:30, 3 hours 23 minutes ago

    Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate

  • Published on 04/09/2026 at 13:30, 3 hours 23 minutes ago

    ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel

View all ACCESSWIRE
EQS Group
  • Published on 04/09/2026 at 15:59, 53 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 04/09/2026 at 15:57, 56 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 04/09/2026 at 15:40, 1 hour 13 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

  • Published on 04/09/2026 at 15:39, 1 hour 13 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

  • Published on 04/09/2026 at 15:39, 1 hour 14 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The

View all EQS
Les Echos
  • Published on 04/09/2026 at 15:57, 55 minutes ago

    Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports

  • Published on 04/09/2026 at 07:00, 9 hours 53 minutes ago

    bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

  • Published on 04/08/2026 at 18:02, 22 hours 51 minutes ago

    Publication of the 2025 Universal Registration Document

  • Published on 04/08/2026 at 17:45, 23 hours 8 minutes ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 04/08/2026 at 12:58, 1 day 3 hours ago

    EURAZEO IS ASSIGNED A BBB CREDIT RATING (STABLE OUTLOOK) BY S&P AND A BBB CREDIT RATING (STABLE OUTLOOK) BY FITCH

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy